pentyl (1-((2R,3R,4S,5R)-4-(((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)oxy)-3-hydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate; 1-[5’-Deoxy-3-O-(5’-deoxy-?-D-ribofuranosyl)-?-D-ribofuranosyl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamic Acid Pentyl Ester; Capecitabine USP Impurity I; 3’-(5’-Deoxy-Alfa-D-ribofuranoyl) Capecitabine; 1-[5’-Deoxy-3-O-(5’-deoxy-α-D-ribofuranosyl)-β-D-ribofuranosyl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamic acid pentyl ester
Capecitabine USP Impurity I is a fully characterized chemical compound used as a reference standard of API Lumacaftor. The standard offered is compliant with regulatory guidelines. Capecitabine USP Impurity I is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
5'-DFUR-13C5 (5'-Deoxy-5-fluorouridine, Doxifluridine-13C5)
M.F.
M.W. 251.22
CAT# AR-C01239
CAS# 3094-09-5 (non-labeled)